Results 151 to 160 of about 1,882,441 (191)

Ruxolitinib for rheumatic disease-associated macrophage activation syndrome in children: a retrospective cohort study. [PDF]

Front Immunol
Zhu X, Zhang M, Yang J, He T.
europepmc   +1 more source

Comorbidities in Juvenile-Onset Rheumatic Diseases: A Systematic Review and Meta-Analysis. [PDF]

Children (Basel)
Siddiq S, Cheetham S, Pain CE, Smith EMD, Zhao SS, McCann LJ, Hughes DM.   +6 more
europepmc   +1 more source

EBV induced Evans syndrome in a patient of SLE related MAS: A case report. [PDF]

Medicine (Baltimore)
Li W, Chen Y, Chen Y, Zhao M, Zhang S.
europepmc   +1 more source

Premature ovarian insufficiency in patients with systemic lupus erythematosus on cyclophosphamide: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
García-Sáenz MR, Ramírez-Rentería C, Espinosa-Cárdenas E, Sosa-Eroza E, Doval-Caballero JLE, Gete Palacios PC, Pazos-Pérez F, Ocampo-Torres MC, Catana-Hernández R, Vázquez-Zaragoza MÁ, Camargo-Coronel A, Gómez-Bernal JR, Ferreira-Hermosillo A.   +12 more
europepmc   +1 more source

Cardiovascular Morbidity in Juvenile-Onset Systemic Lupus Erythematosus

openaire   +1 more source

Low disease activity state in juvenile-onset systemic lupus erythematosus

Lupus, 2021
Objectives To determine the rate of achieving The Lupus Low Disease Activity State (LLDAS) in children with systemic lupus erythematosus (SLE) for tracing pertinent treatment modalities. Methods A total of 122 juvenile-onset SLE (jSLE)
Semanur Ozdel, Esra Baglan, Gülşah Kavrul Kayaalp   +2 more
exaly   +5 more sources

Rituximab therapy for juvenile-onset systemic lupus erythematosus [PDF]

Pediatric Nephrology, 2007
Rituximab (RTX), an anti-CD20 monoclonal antibody, has been proposed for use in the therapy of systemic lupus erythematosus (SLE). We present the initial long-term experience of the safety and efficacy of rituximab for treatment of SLE in children.
Carolyn Abitbol, Wacharee Seeherunvong, Gaston Zilleruelo   +2 more
exaly   +3 more sources

Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study

Joint Bone Spine, 2023
Neuropsychiatric (NP) involvement is a restricted area in juvenile-onset systemic lupus erythematosus (jSLE).To investigate the prevalence, demographic and clinical features, and outcomes of the neurological involvement in the Turkish jSLE population.This study was based upon 24 referral centers' SLE cohorts, multicenter and multidisciplinary network ...
Selcuk Yuksel, Amra Adrovic Yıldız, Sevcan Bakkaloglu   +2 more
exaly   +13 more sources

Juvenile-onset systemic lupus erythematosus (jSLE) – Pathophysiological concepts and treatment options

Best Practice and Research in Clinical Rheumatology, 2017
The systemic autoimmune/inflammatory condition systemic lupus erythematosus (SLE) manifests before the age of 16 years in 10-20% of all cases. Clinical courses are more severe, and organ complications are more common in patients with juvenile SLE. Varying gender distribution in different age groups and increasing severity with younger age and the ...
Christian Hedrich, Michael William Beresford, Eve Smith   +2 more
exaly   +3 more sources